Trueglam Pharmaceuticals Private Limited
About Trueglam Pharmaceuticals Private Limited
Data last updated:
Trueglam Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It was incorporated on 16 March 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U46497DL2023PTC411141.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Saurabh Bansal and Atul Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No 1964/7 3rd Floor Kingsway Camp Outram Line, Landmark Near Hari Mandir Delhi, Delhi, India – 110009.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.88 Lakh, a growth of 131% compared to the previous year. For the same year it recorded a net profit of ₹4,630 (net margin 0.3%) and EBITDA of ₹5,110 (EBITDA margin 0.3%).
Company details
Contact details
Trueglam Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressHouse No 1964/7 3rd Floor Kingsway Camp Outram Line, Landmark Near Hari Mandir Delhi, Delhi, India – 110009
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Trueglam Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Trueglam Pharmaceuticals Private Limited, buy the company report.
Financials of Trueglam Pharmaceuticals Private Limited
FY 2025 filings availableTrueglam Pharmaceuticals Private Limited reported revenue of ₹14.88 Lakh (up 131% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 131% in the latest year. EBITDA rose 97% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹5,110 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹4,630 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.3% | ||
| Net Profit Margin | 0.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Trueglam Pharmaceuticals Private Limited, buy the company report.
Board of directors of Trueglam Pharmaceuticals Private Limited
Trueglam Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saurabh Bansal | Director | 23 Aug 2023 | 3 Years 2 Months | Current |
| Atul Sharma | Director | 23 Aug 2023 | 3 Years 2 Months | Current |
| Umesh Chand Garg | Director | 16 Mar 2023 | 3 Years 7 Months | Current |
| Renu Sharma | Director | 16 Mar 2023 | 3 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Trueglam Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Trueglam Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Trueglam Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Trueglam Pharmaceuticals Private Limited has 4 board changes on record since 2023: 4 appointments. The latest: Atul Sharma was appointed as Director on 23 Aug 2023.
Frequently asked questions
Trueglam Pharmaceuticals is an active private limited company based in Delhi, India. It was incorporated on 16 March 2023 (3+ years old) and is registered under CIN U46497DL2023PTC411141.
Trueglam Pharmaceuticals has 4 current directors:
- Saurabh Bansal - Director
- Atul Sharma - Director
- Umesh Chand Garg - Director
- Renu Sharma - Director
The latest financial statements of Trueglam Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Trueglam Pharmaceuticals is U46497DL2023PTC411141. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Trueglam Pharmaceuticals was incorporated on 16 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
Atul Sharma was appointed as Director on 23 Aug 2023. Saurabh Bansal was appointed as Director on 23 Aug 2023. Renu Sharma was appointed as Director on 16 Mar 2023. Trueglam Pharmaceuticals has 4 board changes on record in total.
The registered office of Trueglam Pharmaceuticals is at House No 19647 3rd Floor Kingsway Camp Outram Line, Landmark Near Hari Mandir Delhi, Delhi, India – 110009.
Trueglam Pharmaceuticals can be reached at its registered office: House No 19647 3rd Floor Kingsway Camp Outram Line, Landmark Near Hari Mandir Delhi, Delhi, India – 110009.
Trueglam Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.